Product Image

Omega 3 Platinum

Zahler
4.8
★ ★ ★ ★ ★
(1502 ratings)
EPA (Eicosapentaenoic Acid) 900 mg
Omega-3 0 NP
DHA 600 mg
Fish Oil 3000 mg
Vitamin E 15 IU
Docosapentaenoic acid 90 mg
Product Image
Score82
Best suited to heart health, with the clearest benefits coming from the disclosed active ingredients. The triglyceride-form fish oil also supplies other omega-3 fats without hiding the key EPA and DHA amounts.
How scoring works
Quantity:360 Softgel(s) • (120 servings)
Goals:
Heart Health
Anti-Inflammatory Support
Skin Health
Cardiovascular Support
Joint Health
Mental Focus
Metabolism Boost

Score 82

Best suited to heart health, with the clearest benefits coming from the disclosed active ingredients. The triglyceride-form fish oil also supplies other omega-3 fats without hiding the key EPA and DHA amounts.
How scoring works
$99.50($0.82 per serving)
Vitacost
$ 117.00
Amazon
$ 99.50
Pure Formulas
$ 104.00
iHerb
$ 117.00
Report prices

Analysis

Substantial EPA and DHA in triglyceride-form fish oil provide a focused option for cardiovascular, inflammatory, skin-barrier, and long-term brain support. The fish species, purification method, and independent contaminant testing are not disclosed, while the concentrated omega-3 amount may increase bleeding tendency with anticoagulant or antiplatelet medicines.

A clearly stated combination of EPA and DHA provides direct, evidence-based cardiovascular support for triglyceride management. The triglyceride-form fish oil also supplies other omega-3 fats without hiding the key EPA and DHA amounts. The focused formula does not cover magnesium, CoQ10, nitric-oxide support, or homocysteine pathways, but it has strong depth in its chosen lipid pathway.

A substantial amount of EPA and DHA may support lipid handling and insulin-related metabolic health, but it is not a thermogenic or direct metabolic-rate intervention. The concentrated fatty-acid strategy is more relevant to long-term cardiometabolic support than an immediate metabolism boost. Triglyceride-form fish oil supports absorption, and EPA and DHA amounts are clearly disclosed.

Who is it for
  • People seeking heart health support
  • People seeking anti-inflammatory support support
  • People seeking skin health support
Best for
  • Heart Health
  • Anti-Inflammatory Support
  • Skin Health

Pros

  • Substantial EPA and DHA in triglyceride-form fish oil provide a focused option for cardiovascular, inflammatory, skin-barrier, and long-term brain support.
  • A clearly stated combination of EPA and DHA provides direct, evidence-based cardiovascular support for triglyceride management.
  • Fish oil can increase bruising or bleeding tendency at higher intakes, especially with anticoagulant or antiplatelet medicines.
  • A high amount of EPA and DHA in triglyceride-form fish oil directly supports production of inflammation-resolving mediators.
  • The formula is focused and provides a clinically meaningful omega-3 contribution.

Cons

  • The triglyceride-form fish oil also supplies other omega-3 fats without hiding the key EPA and DHA amounts.
  • The focused formula does not cover magnesium, CoQ10, nitric-oxide support, or homocysteine pathways, but it has strong depth in its chosen lipid pathway.
  • Purification or independent contaminant testing is not stated, which leaves one quality detail unresolved.
  • The focused oil does not provide cartilage building blocks or joint lubrication actives.
  • The formula does not include an alertness, neurotransmitter, or stress-resilience active for acute focus.

Warnings

  • The fish species, purification method, and independent contaminant testing are not disclosed, while the concentrated omega-3 amount may increase bleeding tendency with anticoagulant or antiplatelet medicines.
  • Fish oil can increase bruising or bleeding tendency at higher intakes, especially with anticoagulant or antiplatelet medicines.
  • Fish oil may increase bleeding tendency with anticoagulant or antiplatelet medicines, and it is unsuitable for people with a clinically significant fish allergy.
  • The concentrated omega-3 amount may increase bruising or bleeding tendency when combined with anticoagulant or antiplatelet medicines.
  • Fish oil may add to bleeding risk when combined with anticoagulant or antiplatelet medicines, especially around procedures.

Nutrient quality

90 Highest impact

Triglyceride oil and substantial EPA and DHA amounts provide strong dose and form quality. Moderate concentration and missing fish-species details keep the formula from full quality assurance.

Ingredient transparency

79 High impact

EPA, DHA, other omega-3 fats, and the carrier oil all have stated amounts. Daily directions and complete excipient details are not supplied.

Customer satisfaction

75 High impact

The supplied aggregate satisfaction metric is strong and supported by the available feedback volume. No feedback excerpts or complaint themes are supplied, so specific experience patterns cannot be verified.

Value for money

83 Highest impact

Serving value appears reasonable but not exceptional. The focused ingredient profile avoids costly low-value extras.

Report analysis

Goals

Heart Health
Impact
Highest effect
A+ Goal FitA Strength of SupportB- CoverageA Formula Quality
EPA (Eicosapentaenoic Acid) · 900 mg

A clearly stated combination of EPA and DHA provides direct, evidence-based cardiovascular support for triglyceride management. The triglyceride-form fish oil also supplies other omega-3 fats without hiding the key EPA and DHA amounts.

The focused formula does not cover magnesium, CoQ10, nitric-oxide support, or homocysteine pathways, but it has strong depth in its chosen lipid pathway. Fish oil can increase bruising or bleeding tendency at higher intakes, especially with anticoagulant or antiplatelet medicines.

Study evidence
Anti-Inflammatory Support
Impact
Highest effect
A Goal FitA Strength of SupportB+ CoverageA Formula Quality
Fish Oil · 3000 mgVitamin E · 15 IU

A high amount of EPA and DHA in triglyceride-form fish oil directly supports production of inflammation-resolving mediators. The formula is focused and provides a clinically meaningful omega-3 contribution.

EPA and DHA are separately disclosed, and vitamin E helps protect the oil from oxidation. Purification or independent contaminant testing is not stated, which leaves one quality detail unresolved.

Study evidence
Fish Oil Supportive 68 studies
Vitamin E Supportive 20 studies
Skin Health
Impact
Highest effect
A- Goal FitA Strength of SupportB+ CoverageA+ Formula Quality
Vitamin E · 15 IUOmega-3 · 1860 mg

A substantial triglyceride-form omega-3 amount provides direct support for skin barrier lipids and inflammatory balance. Natural vitamin E adds complementary antioxidant protection.

The formula focuses deeply on lipid and barrier pathways rather than collagen or hyaluronic-acid support. Fish oil may increase bleeding tendency with anticoagulant or antiplatelet medicines, and it is unsuitable for people with a clinically significant fish allergy.

Study evidence
Omega-3 Supportive 35 studies
Vitamin E Supportive 38 studies
Cardiovascular Support
Impact
Highest effect
A Goal FitA- Strength of SupportB CoverageA Formula Quality
Fish Oil · 3000 mgVitamin E · 15 IU

A substantial triglyceride-form fish oil dose provides direct and well-supported cardiovascular value. Clearly listed EPA and DHA make the effective amount easy to judge.

The formula is intentionally focused on lipid and inflammatory balance rather than broad pathway coverage. The concentrated omega-3 amount may increase bruising or bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Study evidence
Fish Oil Supportive 185 studies
Vitamin E Mixed 79 studies
Joint Health
Impact
Highest effect
B Goal FitA- Strength of SupportC+ CoverageA Formula Quality
Omega-3 · 1860 mg

Concentrated triglyceride fish oil provides strong EPA and DHA support for inflammatory balance. The expected value depends on the pathway the formula actually covers.

The focused oil does not provide cartilage building blocks or joint lubrication actives. Joint changes are gradual and should be judged through mobility and comfort over consistent use.

Study evidence
Omega-3 Supportive 40 studies
Mental Focus
Impact
High effect
B Goal FitA- Strength of SupportD+ CoverageA+ Formula Quality

Substantial triglyceride-form DHA and EPA provide a strong long-term brain-lipid foundation. The formula does not include an alertness, neurotransmitter, or stress-resilience active for acute focus.

Exact omega-3 amounts and molecular form are clear quality strengths. Fish oil may add to bleeding risk when combined with anticoagulant or antiplatelet medicines, especially around procedures.

Study evidence
Metabolism Boost
Impact
High effect
D+ Goal FitA- Strength of SupportC- CoverageA Formula Quality
Omega-3 · 1860 mg

A substantial amount of EPA and DHA may support lipid handling and insulin-related metabolic health, but it is not a thermogenic or direct metabolic-rate intervention. The concentrated fatty-acid strategy is more relevant to long-term cardiometabolic support than an immediate metabolism boost.

Triglyceride-form fish oil supports absorption, and EPA and DHA amounts are clearly disclosed. The fish species and independent purity testing are not supplied, leaving sourcing quality incomplete.

Study evidence
Omega-3 Supportive 42 studies

Ingredients

IngredientAmount per serving
Vitamin E
15 IU
Kosher TG Fish Oil
3000 mg
Omega-3 Fatty Acids
0 NP
Eicosapentaenoic Acid
900 mg
Docosahexaenoic Acid
600 mg
Docosapentaenoic Acid
90 mg
Total Omega-3 Fatty Acids
1860 mg
Gluten Free Adults 18–50 Kosher
Report overview
B Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value

The explicitly identified triglyceride fish oil provides a substantial EPA amount with an EPA-led balance. EPA density is moderate rather than highly concentrated. Vitamin E offers some oxidation protection, but no third-party contaminant testing is stated.

Omega-3 · 0 NP OverallScore71
B- Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyA+ Value

The triglyceride form supports absorption, but the fish species is not identified. EPA and DHA are disclosed separately, but their concentration in the oil is low. The substantial active dose makes the serving highly cost-efficient.

DHA · 600 mg OverallScore66
A- Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyC Value

Triglyceride fish oil provides a well-absorbed DHA form with vitamin E for oxidation protection. The DHA dose is strong, but DHA and EPA account for only about half of the listed oil. Missing contaminant testing and species details weaken safety transparency, while cost efficiency is moderate.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
    Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE; VITAL Research Group · Circulation research · 2020
    Randomized trial25,871 participantsCardiovascular Support forFish Oil
  2. Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials.
    He L; Li MS; Lin M; Zhao TY; Gao P · European journal of clinical pharmacology · 2016
    Meta-analysis916 participants13 studies pooledAnti-Inflammatory Support forFish Oil
  3. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  4. Marine n-3 fatty acid treatment for carotid plaques in patients with type 2 diabetes.
    Zhuang P; Liu X; Jia W; Zheng W; Wan X; Chen W; Gu J; Li Y; Lan X; Li H; Tong W; Wu Y; Wu X; Ao Y; Ye H; Wu F; Zhu L; Zhang L; Li Y; Meng D; Tian Y; Wang A; Wu S; Zhu F; Zhang Y; Shi H; Yu X; Zhang F; Zhang Y; Jiao J · Cardiovascular diabetology · 2026
    Randomized trial415 participantsCardiovascular Support forFish Oil
  5. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals.
    Pot GK; Brouwer IA; Enneman A; Rijkers GT; Kampman E; Geelen A · European journal of clinical nutrition · 2010
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  6. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  7. Fish oil, enriched with polyunsaturated fatty acids of the omega-3-type accelerates the nucleation time in healthy subjects.
    Janowitz P; Swobodnik W; Wechsler JG; Janowitz A; Saal D; Ditschuneit H · Klinische Wochenschrift · 1991
    Non-randomized trial24 participantsCardiovascular Support forFish Oil
  8. Effects of fish oil supplementation on biomarkers of vascular endothelial function in middle-aged and older adults: a randomized controlled trial.
    Quan C; Tang W; Qin Y; Nian Z; Li Z; Mao L · Food & function · 2026
    Randomized trial240 participantsAnti-Inflammatory Support forFish Oil
  9. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  10. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  11. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  12. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  13. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  14. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  15. Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials.
    Chen X; Hong S; Sun X; Xu W; Li H; Ma T; Zheng Q; Zhao H; Zhou Y; Qiang Y; Li B; Li X · Nutrition reviews · 2021
    Meta-analysis927 participants18 studies pooledAnti-Inflammatory Support forFish Oil
  16. Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study.
    Li ZH; Zhong WF; Liu S; Kraus VB; Zhang YJ; Gao X; Lv YB; Shen D; Zhang XR; Zhang PD; Huang QM; Chen Q; Wu XB; Shi XM; Wang D; Mao C · BMJ (Clinical research ed.) · 2020
    Cohort study427,678 participantsCardiovascular Support forFish Oil
  17. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.
    Deike E; Bowden RG; Moreillon JJ; Griggs JO; Wilson RL; Cooke M; Shelmadine BD; Beaujean AA · Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2013
    Randomized trial31 participantsAnti-Inflammatory Support forFish Oil
  18. Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study.
    Chen G; Qian ZM; Zhang J; Zhang S; Zhang Z; Vaughn MG; Aaron HE; Wang C; Lip GY; Lin H · BMJ medicine · 2024
    Cohort study415,737 participantsCardiovascular Support forFish Oil
  19. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  20. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  21. A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer.
    Mocellin MC; Camargo CQ; Nunes EA; Fiates GMR; Trindade EBSM · Clinical nutrition (Edinburgh, Scotland) · 2017
    Meta-analysis475 participants9 studies pooledAnti-Inflammatory Support forFish Oil
  22. Cardiovascular Benefits of Fish-Oil Supplementation Against Fine Particulate Air Pollution in China.
    Lin Z; Chen R; Jiang Y; Xia Y; Niu Y; Wang C; Liu C; Chen C; Ge Y; Wang W; Yin G; Cai J; Clement V; Xu X; Chen B; Chen H; Kan H · Journal of the American College of Cardiology · 2020
    Randomized trial65 participantsCardiovascular Support forFish Oil
  23. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  24. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  25. Effects of delta-tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial.
    Mahjabeen W; Khan DA; Mirza SA; Pervez MA · Phytotherapy research : PTR · 2021
    Randomized trial110 participantsAnti-Inflammatory Support forVitamin E
  26. Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials.
    Saboori S; Shab-Bidar S; Speakman JR; Yousefi Rad E; Djafarian K · European journal of clinical nutrition · 2016
    Meta-analysis495 participants12 studies pooledAnti-Inflammatory Support forVitamin E
  27. Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.
    Khor BH; Narayanan SS; Sahathevan S; Gafor AHA; Daud ZAM; Khosla P; Sabatino A; Fiaccadori E; Chinna K; Karupaiah T · Nutrients · 2018
    Meta-analysis46 studies pooledAnti-Inflammatory Support forVitamin E
  28. Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis.
    Chee NM; Sinnanaidu RP; Chan WK · Journal of gastroenterology and hepatology · 2024
    Meta-analysis8 studies pooledAnti-Inflammatory Support forVitamin E
  29. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.
    Pervez MA; Khan DA; Slehria AUR; Ijaz A · Complementary therapies in medicine · 2021
    Randomized trial71 participantsAnti-Inflammatory Support forVitamin E
  30. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  31. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
    Loffredo L; Perri L; Di Castelnuovo A; Iacoviello L; De Gaetano G; Violi F · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2016
    Meta-analysis16 studies pooledCardiovascular Support forVitamin E
  32. Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
    Chen B; Li Y; Li Z; Hu X; Zhen H; Chen H; Nie C; Hou Y; Zhu S; Xiao L; Li T · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2025
    Randomized trial90 participantsCardiovascular Support forVitamin E
  33. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
    Lonn E; Bosch J; Yusuf S; Sheridan P; Pogue J; Arnold JM; Ross C; Arnold A; Sleight P; Probstfield J; Dagenais GR; HOPE and HOPE-TOO Trial Investigators · JAMA · 2005
    Randomized trial9,541 participantsCardiovascular Support forVitamin E
  34. Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
    Liu Z; He Z; Xing Y · Journal of nutritional science · 2026
    Cohort study34,955 participantsCardiovascular Support forVitamin E
  35. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
    Chin SF; Ibahim J; Makpol S; Abdul Hamid NA; Abdul Latiff A; Zakaria Z; Mazlan M; Mohd Yusof YA; Abdul Karim A; Wan Ngah WZ · Nutrition & metabolism · 2011
    Randomized trial62 participantsCardiovascular Support forVitamin E
  36. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  37. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  38. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  39. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  40. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  41. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  42. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  43. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  44. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  45. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  46. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  47. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  48. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  49. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  50. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  51. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  52. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  53. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  54. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  55. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3
  56. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis.
    Javanbakht MH; Keshavarz SA; Djalali M; Siassi F; Eshraghian MR; Firooz A; Seirafi H; Ehsani AH; Chamari M; Mirshafiey A · The Journal of dermatological treatment · 2011
    Randomized trial45 participantsSkin Health forVitamin E
  57. Serum vitamin E levels and chronic inflammatory skin diseases: A systematic review and meta-analysis.
    Liu X; Yang G; Luo M; Lan Q; Shi X; Deng H; Wang N; Xu X; Zhang C · PloS one · 2022
    Meta-analysis20 studies pooledSkin Health forVitamin E
  58. Evidence-Based Nutritional Interventions in Wound Care.
    Saeg F; Orazi R; Bowers GM; Janis JE · Plastic and reconstructive surgery · 2021
    Systematic review2,339 participants36 studies pooledSkin Health forVitamin E
  59. Effects of tocotrienol on aging skin: A systematic review.
    Ghazali NI; Mohd Rais RZ; Makpol S; Chin KY; Yap WN; Goon JA · Frontiers in pharmacology · 2022
    Systematic reviewSkin Health forVitamin E
  60. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans.
    Stahl W; Heinrich U; Jungmann H; Sies H; Tronnier H · The American journal of clinical nutrition · 2000
    Randomized trialSkin Health forVitamin E